A new preliminary study shows a single 200 mL dose of convalescent plasma (CP) from COVID-19 patients who recently recovered shortened the duration of symptoms, improved oxygen levels and increased the clearance of the virus in patients who were still suffering from the disease. “One dose of convalescent plasma with a high concentration of neutralizing antibodies can rapidly reduce the viral load and tends to improve clinical outcomes”.
You may also like
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
October 20, 2020
Spam Epidemiology and transmission dynamics of COVID-19 in two Indian states
October 1, 2020
Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study
August 17, 2020